InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
twitchy Free
04/22/24 11:06 AM
profile icon
okwife Free
04/19/24 5:47 PM
profile icon
twitchy Free
04/18/24 2:59 PM
profile icon
twitchy Free
03/13/24 5:35 PM
profile icon
cheusmann Free
03/13/24 12:54 PM
profile icon
twitchy Free
03/12/24 5:37 PM
profile icon
twitchy Free
03/12/24 2:32 PM
profile icon
twitchy Free
03/12/24 2:29 PM
profile icon
okwife Free
03/12/24 12:24 PM
Bullish
Bullish
profile icon
twitchy Free
03/12/24 12:20 PM
profile icon
okwife Free
03/12/24 12:14 PM
Bullish
Bullish
profile icon
twitchy Free
03/08/24 4:42 PM
profile icon
twitchy Free
02/21/24 5:25 PM
profile icon
twitchy Free
02/21/24 11:04 AM
profile icon
twitchy Free
02/20/24 4:22 PM
profile icon
twitchy Free
02/20/24 12:36 PM
profile icon
twitchy Free
02/16/24 10:23 AM
profile icon
twitchy Free
02/14/24 3:09 PM
profile icon
twitchy Free
02/09/24 12:50 PM
profile icon
twitchy Free
02/07/24 5:33 PM
profile icon
twitchy Free
02/07/24 2:35 PM
profile icon
twitchy Free
02/07/24 12:18 PM
profile icon
twitchy Free
02/07/24 11:38 AM
profile icon
twitchy Free
02/07/24 11:14 AM
profile icon
twitchy Free
01/30/24 12:26 AM
profile icon
twitchy Free
01/24/24 6:22 PM
profile icon
twitchy Free
12/20/23 9:32 AM
profile icon
twitchy Free
11/15/23 2:19 PM
profile icon
trader_ron PremiumMember
11/14/23 10:04 AM
profile icon
skipsvalue Free
11/13/23 7:19 AM
profile icon
$treet Trader PremiumMember
10/20/23 10:08 AM
profile icon
twitchy Free
09/20/23 10:53 AM
profile icon
twitchy Free
09/19/23 4:52 PM
profile icon
$treet Trader PremiumMember
07/28/23 2:54 PM
profile icon
twitchy Free
07/25/23 12:27 PM
profile icon
$treet Trader PremiumMember
07/20/23 2:06 PM
profile icon
twitchy Free
07/19/23 11:20 AM
profile icon
twitchy Free
07/18/23 1:21 PM
profile icon
twitchy Free
07/17/23 4:26 PM
profile icon
$treet Trader PremiumMember
07/17/23 3:34 PM
profile icon
twitchy Free
07/17/23 11:17 AM

Redwood Scientific Technologies Inc (RSCI) RSS Feed

Followers
216
Posters
901
Posts (Today)
0
Posts (Total)
34573
Created
05/08/08
Type
Free
Moderators


Redwood Scientific Technologies (OTC:RSCI)
Develops and markets FDA registered homeopathic drugs through the application of sublingual strip delivery


Redwood Scientific Technologies, Inc. develops and markets FDA registered over-the-counter drugs that features oral strip delivery technology. Oral strip delivery technology has emerged as an advanced alternative to the traditional tablets, capsules, and liquid medications. Similar in size, shape, and thickness to a postage stamp, oral strips are typically designed for oral administration and work by having the user place the strip on or under the tongue.

These drug delivery options allow the medication to bypass the first pass metabolism thereby making the medication more bioavailable. As the strip dissolves, the drug can enter the bloodstream enterically, buccally or sublingually.

View The End Of The Pill Corporate Video: click here
Phone: (310) 693-5401
Email: info@redwoodscientific.co
To request FREE information click here



 


 

Product Pipeline & Methods Of Distribution

Redwood Scientific Technologies brings technology proof products through a robust distribution method.

 

 

 
 

RST PRODUCTS

YOUTH ESSENTIAL STRIPS SYSTEM (Y.E.S.S.) was carefully developed to combine powerful benefits into a synergistic system of supplements you won’t find anywhere else. All delivered thru the future of thin film delivery strips.

 
 

 


RST LEADERSHIP

Redwood Scientific Technologies is built on experience and proven performance.

Jason Cardiff

CHIEF EXECUTIVE OFFICER AND PRESIDENT


 

Founder of Redwood Scientific Technologies. Founder of First Choice Media. Managed $100M advertising budget. Co-founder of Runaway Products. Developed and launched 7 top 10 infomercials. Founder of Top 5 most recognizable brands in the UK in 2009.






Eunjung Cardiff

CHIEF OPERATIONAL OFFICER


 

Managing director for Canella Direct response media. Ran national ad campaigns for Guthy Renker. Co-founder of Runaway Products.




 



IN THE NEWS
Thin Film Drug Manufacturing to be worth US$15,984.3 Billion by 2024 
 


NEWS PROVIDED BY
Transparency Market Research 
May 31, 2017, 08:30 ET

ALBANY, New York, May 31, 2017 /PRNewswire/ --

Transparency Market Research (TMR) observes that the competition in the global Thin Film Drug Manufacturing Market is moderately high due to a significant level of consolidation. The leading players in the market are Indivior Plc., MonoSol Rx, IntelGenx Corp., and ZIM Laboratories Limited. These players are expected to focus on research and development of advanced products to stay relevant in the competition. Expansion of production facilities and increasing geographical reach will also be key strategies adopted by the companies in the global market.

North America to Lead Global Thin Film Drug Manufacturing Market 

According to the research report, the global thin film drug manufacturing market is expected to be worth US$15,984.3 bn by the end of 2024 from US$7,337.8 mn in 2015. During the forecast years of 2016 and 2024, the global market is projected to exhibit a CAGR of 9.0%. Amongst the various film types, the transdermal thin film is expected to surpass the revenue earnings of others. This segment accounted for a share of 73.6% in the global thin film drug manufacturing market in 2016 and is expected to continue its dominance in the coming years as well. From a geographic point of view, North America is estimated to emerge as a leading regional market. As of 2016, North America thin film drug manufacturing market accounted for a share of more than 66.6% due a structured pharmaceutical industry in the region.
 
The growing demand for efficient drug delivery systems has augmented the uptake of thin film drugs due to their efficiency and effectiveness. The convenience of transportation and storage has encouraged patients to opt for these drugs. Thin film drugs also enable precise dosages to achieve desired outcomes. This factor is also expected to play an instrumental role bolstering the growth of the global market in the coming years. The increasing investments in research and development of newer polymeric thin films as a method of drug deliver has also encouraged market growth. Thin film drugs are poised to gain attention in the healthcare industry as eliminate the disadvantages of associated with conventional forms of dosages such as inconvenience of administration, lower bioavailability, and patient non-compliance among others.  To read this article in its entirety click here.

 



RST PRESS RELEASES


Redwood Scientific Announces Rapid Introduction Of New Products Over Next Three Quarters

LOS ANGELES, August 21, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) the leader in over-the-counter medication delivered in an oral thin-film strip has announced the rapid introduction of new products to the marketplace over the next three quarters.

Redwood Scientific Technologies will be delivering three new products in Q3 of 2017 that will introduce industry-leading scientific advances. Vita-Balance, an adult multi-vitamin, will launch first, representing an enormous breakthrough in the oral thin-film delivery method. It will be the first time the amount of active ingredients has been synthesized down to the dosage required to create an effective, active thin-film strip. Next, RST will launch Capilli-Biotin RX, a hair-growth product that will also include huge benefits for skin and nails. The final product for Q3 will be Ocean-X, with the active ingredient Medazine, which will work to combat motion sickness and nausea. As an oral strip, it will bypass the need to be chewed, then placed under the tongue, for effectiveness.

Jason Cardiff, the company’s founder and CEO, stated, “I am very excited about the next 36 months and the ramp rate and growth of our new products coming to market. We continue to see massive growth in our over-the-counter drugs and look forward to the expansion with new products.

RST has planned to bring nine new products to market by the end of Q4, and is expected to announce the introduction of the company’s first line of children’s products in Q4 as well. By the end of Q3 of 2018, the company is hoping to bring over 20 new products to market each quarter, with a projected growth plan of 200 oral thin-film strip products by the end of 2018. Redwood Scientific Technologies has also reported they are on track to develop the first oral thinfilm strip to be delivered as a prescription-only treatment for internal infections. In addition, the company’s science team has reported new developments in creating an oral thin-film strip that will hold antibiotics. RST’s head of pediatric treatments, Dr. Oyemade, stated, “This will be the greatest treatment and delivery method we have seen in modern medicine in over 100 years.”




Redwood Scientific To Bring First Oral Thin Film Antibiotic To Market

LOS ANGELES, May 1, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) announces that is has started the beginning stages of bringing antibiotics to market in the successful oral thin film method.

It will be the first RST products that is not over the counter and will require a prescription. The first antibiotic will be Azithromycin. The company has stated they have already started the FDA process and is in its initial testing. RST has achieved the same successful results in combining the active ingredient into the OTF strip verses the tablet form. RST also believes that it could have products on the shelf in pharmacies by the third quarter of 2019. This will be the first of several prescriptions based applications to be developed by the world leader in OTF medication.




Redwood Scientific Launching Latest Product - Eupepsia Thin™

LOS ANGELES, April 1, 2017 /PRNewswire/ -- Redwood Scientific Technologies, Inc (RST) is launching its latest product, Eupepsia Thin.

Redwood Scientific Technologies, Inc (RST) is launching its latest product, Eupepsia Thin. Like all RST products, it is an OTF based product (oral thin film). It will dissolve in your mouth in about 20 seconds and from there works to suppress your appetite and creates a feeling of fullness. The Chief Medical Officer at RST states that, the issue we have with obesity and the lack of successful dieting is the that we are consuming 2,500 plus more calories per day than we are expending. With Eupepsia Thin, you have the desire to eat less even when you are confronted with foods you love in super-sized portions.

Redwood believes that, with healthy eating and average exercise, their new product Eupepsia Thin is the answer to the diet roller coaster.




TBX-FREE Sales Surpass 10,000 Units Sold

LOS ANGELES, April 6, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced that it has sold over 10,000 units of TBX-FREE since the product first launched in December of 2015.

"We are incredibly proud of the progress TBX-FREE has made in helping smokers around the world quit their harmful addiction to cigarettes," said Jason Cardiff, President and CEO. "Smokers are clearly responding well to the benefits offered by the oral strip delivery technology that is in TBX-FREE. Simply put: pills, patches, and lozenges are obsolete methods of drug delivery, and given the high number of smokers who fail at quitting; they clearly are ineffective."

According to the CDC, there are an estimated 40 million smokers within the United States. With such a large amount of potential customers, TBX-FREE is poised to obtain a huge market presence by providing an effective alternative to nicotine replacement therapy. Even more noteworthy is that TBX-FREE has passed the 10,000 units sold mark in the space of only 3 months.

Additionally, customers who complete their first month of TBX-FREE will now receive supplemental material that includes instructions for after their first 30 days, important information on smoking recurrence, a certificate of completion, and other helpful items.

About Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.




Dr. Salah Zaki Appointed Chief Medical Officer at Redwood Scientific Technologies, Inc.

LOS ANGELES, March 4, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced that it has appointed M. Salah Zaki, M.D., as Chief Medical Officer. In this role, Dr. Zaki will oversee scientific research, assist with FDA registration, medical regulation, product development, and global expansion.

"Dr. Zaki brings a vast wealth of medical experience to Redwood during a time when our company is rapidly growing," said Jason Cardiff, President and CEO. "His recruitment as Chief Medical Officer represents our confidence that not only will the company produce incredibly sophisticated products in the future but also that our growth necessitates additional scientific expertise. With the aid of his impressive international experience, Redwood Scientific Technologies will be positioned to expand into foreign markets."

Dr. Zaki joins Redwood from his previous position as the President and CEO of International Medical Consultants. He graduated 6th in his class from the prestigious Al Azhar University Medical School in Cairo, Egypt. As a cardiac surgeon, he has integrated Western medical practices into his work throughout the Middle East. In 2009, he was appointed by the U.S. Embassy in Egypt to be the official medical liaison during President Barack Obama's visit. From 1995-2006, he was Medical Director of the International Department of the Washington Hospital Center. In 1995, Dr. Zaki developed an international patient program to expand the Washington Hospital Center's communications worldwide. In 2001, he was appointed as the first President of the Institute of International Health at the George Washington University Medical Center and also as Medical Director of the International Program at Georgetown University Hospital. He has also served as medical advisor to the Armed Forces of the UAE.

About Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.




Redwood Scientific Technologies Announces TBX-FREE Completes FDA Registration

LOS ANGELES, Feb. 12, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. (Redwood) today announced the unveiling of Blossom: a new oral strip product designed to balance hormones in women.

"Blossom will take the female personal care market by storm and give women the power to enjoy balanced hormones," said Jason Cardiff, President and CEO. "Millions of women around the nation and throughout the world will enjoy more satisfying sex lives, more powerful orgasms, and improved libidos. Now women will have the opportunity to improve their sexual performance."

Using Redwood Scientific Technologies' advanced oral strip delivery technology, Blossom can help women get immediate hormone balancing benefits. Ingredients inside Blossom include fenugreek extract, L-arginine, and red ginseng. When combined together, these ingredients can increase the sexual pleasure women enjoy by balancing their hormones and allowing greater sensitivity during intercourse along with increased arousal.

A marketing and advertising campaign for Blossom is expected to launch in the second quarter of 2016.

About Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.




Redwood Scientific Technologies Announces TBX-FREE Completes FDA Registration

LOS ANGELES, Feb. 5, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. announced today the development and launch of a new product designed to help women balance their hormones. This product will be featuring Redwood's innovative oral strip delivery technology.

"For too long, women have gone without access to a product that helps them properly balance their hormones," said Jason Cardiff, President and CEO. "I am proud that our company will be able to help the millions of women across the country and around the world who suffer from the effects of imbalanced hormones. Our research and development team is confident that through the use of oral strip delivery technology we can truly impact the lives of women all over the world."

Oral strip delivery technology allows for the immediate delivery of medicinal ingredients into the bloodstream by way of the mouth. When oral strips enter the mouth, they dissolve within seconds and begin entering the circulatory system. In contrast to this, pills, capsules, and liquid medication take several hours to pass through the digestive system in order for their benefits to be felt. Oral strips bypass the digestive system and are not a choking hazard. Additionally, oral strip delivery technology is not as irritating or sneeze-inducing as inhalants.

The all-natural hormone balancing product for women will be formulated to not only increase sexual pleasure but also arousal and stimulation during intercourse. The upcoming product works by increasing blood flow to the erogenous zones and increasing lubrication which in turn allows women to enjoy improved sensitivity. As a result, women who take the upcoming product will be able to have faster and more pleasurable orgasms.

The name of the product and additional details will be revealed before Valentine's Day to coincide with the romantic holiday.

About Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.




Redwood Scientific Technologies Announces TBX-FREE Completes FDA Registration

LOS ANGELES, Oct. 13, 2015 /PRNewswire/ -- Redwood Scientific Technologies, Inc. ("Redwood") today announced it has completed the Food & Drug Administration (FDA) registration process for TBX-FREE to be classified as an over-the-counter homeopathic drug under National Drug Code: 69305-001-01. The completion of the registration process is the result of diligent cooperation with FDA counsel in order to obtain compliance for the key ingredient in TBX-FREE.

"Compliance with FDA regulations is an essential prerequisite to Redwood products being vetted and approved for sale on the shelves of national pharmacy retail locations," said Eunjung Cardiff, Director of Marketing at Redwood. "We expect to announce initial availability of TBX-FREE within the next three months."

TBX-FREE is a thin film stop smoking aid that features cytisine as its key ingredient. Cytisine has the unique property of making smokers feel the same pleasurable sensations as if they were smoking real cigarettes. It also has the power to make smoking cigarettes feel less pleasurable.

"TBX-FREE will be available for purchase without a prescripti